Back to results
US 12,594,351 B2Granted
Methods for increasing shelf-life of ophthalmic pharmaceutical compositions
AssigneeHarrow IP, LLC
InventorsErnesto Fernandez, William F. Wiley, Dennis Elias Saadeh
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods for extending the shelf life of a sterile ophthalmic pharmaceutical composition.
Claims13
A method for extending the shelf life of a sterile, preservative-free, ophthalmic pharmaceutical composition, the method comprising:
- autoclaving a first phase composition consisting of prednisolone or a pharmaceutically acceptable salt thereof, sodium acetate, sodium chloride polyoxyethylene sorbitan monooleate, hydroxypropyl methylcellulose, optionally hydrochloric acid, optionally sodium hydroxide, and water;
- autoclaving or sterile filtering a second phase composition consisting of moxifloxacin, bromfenac, sodium phosphate, sodium metabisulfite, edetate disodium, boric acid, sodium borate, optionally hydrochloric acid, optionally sodium hydroxide, and water;
- and
- combining the first phase composition and the second phase composition, aseptically,
- wherein the ophthalmic pharmaceutical composition has a shelf life that is at least 90 days when stored at room temperature.
2 more elements
Dependencies are inferred from the claim text.